8-K - Lexicon Pharmaceuticals, Inc. | StockGist

Current Report Details

Event Type

Financial Results+3 More

Disclosure

Mandatory

Variant

8-K

Items Reported

2.02

Results of Operations and Financial Disclosure The Company previously announced that it ended 2025 with cash, investments and restricted cash of $125.2 million

Financial Results

$10.0M$20.0M

7.01

shall not be deemed an admission as to the materiality of any information in this Current Report that is required to be disclosed solely to satisfy the requirem

Regulation Fd

8.01

Other Events The information set forth in Item 2.02 of this Current Report is hereby incorporated in this Item 8.01 by reference. On January 29, 2026, the Compa

Other Event

9.01

Financial Statements and Exhibits (d) Exhibits. Exhibit Number Description 99.1 Launch Press Release, dated January 29, 2026. EX-104 Cover Page Interactive Data

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EX-99.1